Christopher Vanderneck
Family Medicine · Henderson, NENPI 1366455974
Payments from drug & device makers
Across 165 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$280
- AbbVie$266
- Novo Nordisk$248
- Johnson & Johnson$223
- Pfizer$209
- Astellas Pharma US Inc$188
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,46096%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 23 | $280 |
| AbbVie(2 entities) | 17 | $266 |
| Novo Nordisk | 18 | $248 |
| Johnson & Johnson | 14 | $223 |
| Pfizer | 16 | $209 |
| Astellas Pharma US Inc | 7 | $188 |
| Amgen | 13 | $173 |
| Aimmune Therapeutics, Inc. | 2 | $114 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| Boehringer Ingelheim | 7 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $86 |
| Bayer | 5 | $71 |
| GSK | 5 | $69 |
| Merck | 4 | $65 |
| AstraZeneca | 4 | $53 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Medicure Pharma Inc. | 1 | $48 |
| Seqirus USA Inc | 2 | $34 |
| Philips North America LLC | 2 | $27 |
| Genentech USA, Inc. | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,560 in reported general payments places this provider in the 75th percentile of 981 family medicine providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $39,319 |
| JardianceEmpagliflozin | 40 | $34,282 |
| OzempicSemaglutide | 31 | $26,965 |
| TrulicityDulaglutide | 24 | $24,080 |
| EntrestoSacubitril/Valsartan | 11 | $7,424 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,113 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $3,659 |
| Losartan Potassium | 119 | $1,749 |
| Tamsulosin Hcl | 109 | $1,672 |
| Atorvastatin Calcium | 114 | $1,487 |
| Humalog Kwikpen U-100Insulin Lispro | 11 | $1,486 |
| Carbamazepine ErCarbamazepine | 14 | $1,478 |
| Pantoprazole Sodium | 113 | $1,462 |
| Amlodipine Besylate | 166 | $1,340 |
| Memantine Hcl | 23 | $1,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $209 | $39,31959 claims |
| Boehringer IngelheimJardiance | $103 | $34,28240 claims |
| Novo NordiskOzempic | $248 | $26,96531 claims |
| Lilly USA, LLCTrulicity | $280 | $24,08024 claims |
| GSKTrelegy Ellipta | $69 | $7,11311 claims |
| AbbVieSynthroid | $266 | $47318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Henderson
- Brandon EssinkCreighton$92.8M
- Adam BroszGrand Island$60M
- David EnszSouth Sioux City$33.3M
- Allen HuntLincoln$17.2M
- Thomas WolfFremont$8.2M
- William FitzgibbonsElkhorn$7M
- Kenneth BladOmaha$1.6M
- Lorrie McGillPapillion$1.5M
- Ralph HaukeOmaha$657K
- Darin GregoryOmaha$423K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.